Broadcasting News

Actor Lee Sang-yi Shares His First Thoughts Since the Passing of the Late Park Dong-bin… “I Miss You, I Love You”

The late Park Dong-bin passed away last April due to heart disease… at the age of 56

JOO MEE_HEE
2026-08-02 10:31:30
[Edaily Starin JOO MEE_HEE Reporter] Actress Lee Sang-i shared her feelings for the first time on social media following the passing of her husband, the late Park Dong-bin.
From left: Actress Lee Sang-i and the late Park Dong-bin. (Photo: Lee Sang-i’s Instagram)

On the 1st, Lee Sang-i posted a photo on her social media along with the brief caption, “I miss you. I love you.” The photo shows the late Park Dong-bin swinging side-by-side with their daughter, Ji-yu, during his lifetime.
This is the first time Lee Sang-i has expressed her longing for her husband on social media since his passing last April.
The late Park Dong-bin, known to the public as “Uncle Juice,” was found dead on April 29 at a restaurant in Jang-an-dong, Pyeongtaek, Gyeonggi Province. He was 56 years old, and the cause of death was reported to be heart disease.
Lee Sang-i and the late Park Dong-bin met while filming the drama *Enemies in a Past Life* and married in 2020; they have a daughter, Ji-yu.

Economy

Corporation

IT·Science

Economy

Concerns Over a Slowdown in AI Investment Following the U.S. Midterm Elections… 'Warning Signs' for South Korean Semiconductors as China Catches Up

“China’s Changxin Memory is catching up at an astonishing pace. Having rapidly dominated the general-purpose semiconductor market, it is now challenging the high-specification semiconductor and high-b…
2026-11-13 17:18:35

Corporation

Burdened by Raw Material Costs and Voluntary Retirement Expenses… Pulmuone Corporate’s Third-Quarter Operating Profit Down 89.6%

Pulmuone Corporate’s operating profit for the third quarter of this year fell to one-tenth of the level recorded in the same period last year. Although sales increased, profitability in its domestic b…
2026-11-13 16:40:27

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02